Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
T-cell engagers
Pharma
Amgen’s Imdelltra scores overall survival win in first-line SCLC
Amgen's R&D chief Jay Bradner said the DLL3 drug stands to “further revolutionize the standard for survival earlier in the treatment journey.”
Angus Liu
Sep 8, 2026 11:42am
J&J bispecific combo delivers 89% PFS benefit in myeloma
Jul 23, 2026 8:30am
AbbVie, Genmab's Epkinly redeems itself in DLBCL
Jun 30, 2026 9:50am
ASCO: Incyte positions Monjuvi combo for first-line DLBCL
May 30, 2026 8:00am
Novartis stands by $5B Pluvicto goal despite EU regulatory setback
Apr 28, 2026 10:10am
Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia
Mar 6, 2026 9:35am
